http://www.shionogi.com/eu/en/http://www.shionogi.com/eu/en/sitemap.htmlhttp://www.shionogi.com/eu/en/references.htmlhttp://www.shionogi.com/eu/en/news.htmlhttp://www.shionogi.com/eu/en/news/press-releases.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2020.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2020/03/shionogi-receives-positive-chmp-opinion-for-fetcroja-cefiderocol.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2020/10.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2020/10/e-201014.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20190/02/190222.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20190/02/190222-2.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20190/04/190404.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20190/04/190401.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20190/04/190403.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20190/04/190411.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20190/05/190521.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20190/06/190619.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20180/04/180418.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20171/03/170323.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20171/03/170324.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20171/03/170330.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20171/10/171012.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20171/12/171205.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20161/12/161219.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20161/02/160215.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20161/02/160219.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20161/02/160229.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20151/01/150119.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20151/03/150330.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20151/06/150624.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20151/07/150707.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20151/08/150803.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20151/09/150928.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20141/09/140904.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/02/130204.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/02/130218.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/02/130226.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/03/130307.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/03/130325.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/03/130326.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/03/130327.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/04/130408.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/05/130507.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/06/130603.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/06/130628.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/08/130813.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/09/130904.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20131/09/130913.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/01/120118.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/01/120125.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/02/120222.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/03/120321.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/03/120321-2.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/03/120330.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/04/120402.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/04/120426.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/05/120525.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/05/120528.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/06/120628.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/07/120705.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/07/120711.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/07/120726.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/07/120730.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/07/120730-2.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/08/120801.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/08/120808.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/08/120810.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/08/120810-2.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/08/120831.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/10/121001.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/10/121024.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/10/121029.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/10/121031.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/11/121114.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20121/12/121218.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/01/110110.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/02/110203.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/03/110315.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/04/110401.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/04/110407.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/04/110422.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/08/110801.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/08/110818.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/08/110831.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/10/111003.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/11/111118.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20111/11/111129.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/01/100113.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/01/100120.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/01/100126.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/01/100125.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/02/100215.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/03/100302.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/04/100416.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/06/100601.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/07/100723.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/07/100729.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/10/101004.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/10/101015.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/10/101021.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/10/101027.htmlhttp://www.shionogi.com/eu/en/news/press-releases/20101/10/101028.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2022.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2022/03.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2022/03/e_160322.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2022/09.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2022/09/20220928.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2022/10.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2022/10/Shionogi_MedicinesPatentPool.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2022/11.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2022/11/Xocova_approvedinJapan.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2022/11/Shionogi_NewEuropeanHeadquartersinAmsterdam_herengracht464.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/02.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/02/EnsitrelvirCOVID19AntiviralClinicalProgram.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/02/ShionogiPresentsPhase3DataandExploratoryLongCOVIDDataatCROI.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/02/Antibiotic_is_now_available_in_the_Netherlands.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/03.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/04.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/04/ECCMID2023Shionogi_PresentDataShowing_COVID19_Symptom_Recurrence.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/04/Shionogi_Receives_FDA_FastTrack_Designationfor_Ensitrelvir_Fumaric_Acid_for_COVID19.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/04/ECCMID_2023_Shionogi_Announces_RWE_Against_Some_of_the_Most_Difficult_to_Treat_GramNegative_Bacterial_Pathogens.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/05.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/06.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/06/MedicinesPatentPool_to_produce_generic_versions_of_Oral_antiviral.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/07.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/07/Shionogi_Planned_Acquisition_Qpex_Biopharma_Inc.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/09.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/09/New_model_accelerates_access_to_important_antibiotics.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/09/Reinforcing_Potential_Across_COVID19_Populations_ESWI23.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/09/Fragile_X_Syndrome_Rare_Pediatric_Disease.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/10.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/10/COVID19_Data_Real_World_and_Clinical_Settings_at_IDWeek_2023.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/12.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2023/12/Shionogi_announces_agreement_with_SOBI.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/02.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/02/Shionogi_Announces_New_Phase3_COVID_19_Data.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/03.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/03/Shionogi_Standard_Approval_in_Japan.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/04.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/04/Orphan_Medicinal_Product_Designation_Fragile_X_Syndrome.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/04/ESCMID2024_Shionogi_presents_real_world_data.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/05.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/05/Shionogi_and_Maze_Therapeutics_Inc_Announce_Exclusive_Worldwide_License_Agreement.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/06.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/10.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/10/IDWeek2024_ShionogiPresentsLargestGlobal_Real-WorldEvidenceStudy.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/10/Shionogi_UBE_CorporationReceiveUS_FDA_FastTrackDesignation_Novel_Anti-Respiratory_Syncytial_Virus.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2024/10/Shionogi_Global_Ph3_Trial_Demonstrates_Post-Exposure_Prophylactic_Use_Prevents_Symptomatic_COVID-19.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/01.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/01/Shionogi_Announces_Positive_Results_Phase2_Human_Challenge_Trial_RSV_Oral_Antiviral.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/03.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/03/SCORPIO_PEP_Phase_3Trial_COVID19_oral_antiviral_to_demonstrate_prevention_of_COVID19_as_post_exposure_prophylaxis.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/04.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/04/ESCMID2025_PROVE_PRESS_RELEASE_080425.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/05.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/05/Collaborative_Research_Agreement_on_Hearing_Loss.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/11.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/11/ShionogiEurope_turns_PaddingtonHQ_blue_World_AMR_AwarenessWeek25.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/12.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2025/12/UniversityBirmingham_UniversityWarwick_partner_Shionogi_toAdvance_Inclusive_Cognition_Research_for_People_with_Intellectual_Disabilities.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2026.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2026/03.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2026/03/Shionogi_First_Patient_Global_PhII_Trial_LateOnset_Pompe_Disease.htmlhttp://www.shionogi.com/eu/en/news/press-releases/2026/03/Shionogi_Announces_JapanApproval_Supplemental_Indication_for_Post_Exposure_Prophylaxis_COVID_19.htmlhttp://www.shionogi.com/eu/en/news/media-enquiries.htmlhttp://www.shionogi.com/eu/en/investors.htmlhttp://www.shionogi.com/eu/en/worldwide.htmlhttp://www.shionogi.com/eu/en/sponsor-s-privacy-notice-for-principal-investigator-and-study-personnel.htmlhttp://www.shionogi.com/eu/en/privacy-notice-for-employees-workers-contractors-job-applicants.htmlhttp://www.shionogi.com/eu/en/about-shionogi.htmlhttp://www.shionogi.com/eu/en/about-shionogi/who-we-are.htmlhttp://www.shionogi.com/eu/en/about-shionogi/global-affiliates-and-locations.htmlhttp://www.shionogi.com/eu/en/about-shionogi/shionogi-bv-tax-strategy.htmlhttp://www.shionogi.com/eu/en/about-shionogi/transparency.htmlhttp://www.shionogi.com/eu/en/about-shionogi/transparency/UKPA.htmlhttp://www.shionogi.com/eu/en/about-shionogi/investor-relations.htmlhttp://www.shionogi.com/eu/en/about-shionogi/investor-relations/cushion-page.htmlhttp://www.shionogi.com/eu/en/about-shionogi/investor-relations/cushion-page1.htmlhttp://www.shionogi.com/eu/en/about-shionogi/Grants_Donations.htmlhttp://www.shionogi.com/eu/en/about-shionogi/Grants_Donations/cushion-page.htmlhttp://www.shionogi.com/eu/en/about-shionogi/heritage-values.htmlhttp://www.shionogi.com/eu/en/about-shionogi/heritage-values/our-values.htmlhttp://www.shionogi.com/eu/en/about-shionogi/leadership-team.htmlhttp://www.shionogi.com/eu/en/cookie-policy.htmlhttp://www.shionogi.com/eu/en/cookie-policy/cushion-page.htmlhttp://www.shionogi.com/eu/en/cookie-policy/cushion-page1.htmlhttp://www.shionogi.com/eu/en/cookie-policy/cushion-page2.htmlhttp://www.shionogi.com/eu/en/privacy-policy.htmlhttp://www.shionogi.com/eu/en/privacy-policy/cushion-page.htmlhttp://www.shionogi.com/eu/en/privacy-policy/cushion-page1.htmlhttp://www.shionogi.com/eu/en/privacy-policy/cushion-page2.htmlhttp://www.shionogi.com/eu/en/privacy-policy/cushion-page3.htmlhttp://www.shionogi.com/eu/en/careers.htmlhttp://www.shionogi.com/eu/en/careers/Open_Positions.htmlhttp://www.shionogi.com/eu/en/careers/Our_People.htmlhttp://www.shionogi.com/eu/en/careers/Vision_and_Values.htmlhttp://www.shionogi.com/eu/en/careers/Diversity-inclusion.htmlhttp://www.shionogi.com/eu/en/careers/benefits-learning-development.htmlhttp://www.shionogi.com/eu/en/careers/meet-hr-business-partners.htmlhttp://www.shionogi.com/eu/en/innovation.htmlhttp://www.shionogi.com/eu/en/innovation/our-areas-of-focus.htmlhttp://www.shionogi.com/eu/en/innovation/our-partners.htmlhttp://www.shionogi.com/eu/en/innovation/our-partners/partnerships.htmlhttp://www.shionogi.com/eu/en/innovation/our-partners/partnership-highlights.htmlhttp://www.shionogi.com/eu/en/innovation/our-partners/what-are-we-looking-for.htmlhttp://www.shionogi.com/eu/en/innovation/science-program.htmlhttp://www.shionogi.com/eu/en/innovation/DrugDiscovery2.htmlhttp://www.shionogi.com/eu/en/innovation/AMR.htmlhttp://www.shionogi.com/eu/en/innovation/global-innovation.htmlhttp://www.shionogi.com/eu/en/innovation/strategic-partnering-in-europe.htmlhttp://www.shionogi.com/eu/en/innovation/strategic-partnering-in-europe/current-capabilities.htmlhttp://www.shionogi.com/eu/en/innovation/strategic-partnering-in-europe/european-operations.htmlhttp://www.shionogi.com/eu/en/innovation/strategic-partnering-in-europe/meet-the-team.htmlhttp://www.shionogi.com/eu/en/innovation/strategic-partnering-in-europe/partnering-licensing-interests.htmlhttp://www.shionogi.com/eu/en/innovation/grants-donations.htmlhttp://www.shionogi.com/eu/en/innovation/working-with-patients.htmlhttp://www.shionogi.com/eu/en/innovation/leavingshionogieu.htmlhttp://www.shionogi.com/eu/en/innovation/leavingshionogieu1.htmlhttp://www.shionogi.com/eu/en/innovation/leavingshionogieu2.htmlhttp://www.shionogi.com/eu/en/innovation/leavingshionogieu511.htmlhttp://www.shionogi.com/eu/en/contact-us.htmlhttp://www.shionogi.com/eu/en/contact-us/cushion-page.htmlhttp://www.shionogi.com/eu/en/report-side-effect.htmlhttp://www.shionogi.com/eu/en/report-side-effect/cushion-page.htmlhttp://www.shionogi.com/eu/en/pdf.htmlhttp://www.shionogi.com/eu/en/PIL_lusutrombopag.htmlhttp://www.shionogi.com/eu/en/privacy-notice-for-mi-pv-and-pqcs.htmlhttp://www.shionogi.com/eu/en/terms-of-use.htmlhttp://www.shionogi.com/eu/en/sustainability.htmlhttp://www.shionogi.com/eu/en/sustainability/tax-strategy.htmlhttp://www.shionogi.com/eu/en/sustainability/governance-policies-position-statements.htmlhttp://www.shionogi.com/eu/en/sustainability/transparency.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu.htmlhttp://shionogi-prod.adobecqms.netleavingshionogieuhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu2.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu3.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu4.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu5.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu51.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu511.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu512.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu513.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu6.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu7.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu8.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu9.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu514.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu515.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu10.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu11.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu516.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu517.htmlhttp://www.shionogi.com/eu/en/sustainability/leavingshionogieu12.htmlhttp://www.shionogi.com/eu/en/sustainability/carbon_reduction_plan.htmlhttp://www.shionogi.com/eu/en/sustainability/sustainability.htmlhttp://www.shionogi.com/eu/en/privacy-notice-for-healthcare-professionals-hcps-and-other-relevant-decision-makers.html